Dengue Vaccines Industry Soars with 12.9% CAGR to Reach US$1603.7 Million by 2033 | FMI Insights

The dengue vaccine industry is on a promising growth trajectory, with an estimated valuation of US$ 474.8 million in 2023. Anticipated demand for dengue vaccines is set to surge, with a projected sales volume CAGR of 12.9%. Dengue vaccine development has reached a pivotal phase in its lifecycle, marked by several pharmaceutical industry leaders poised to unveil …

Dengue Vaccines Market Demand: Strong Pipeline to Rapidly Surge Growth

Increasing prevalence of dengue fever throughout the Asia-Pacific region has propelled the demand for effectual medicines and vaccines to overcome this viral disease. While some pharmaceutical companies are focusing on development of a cure to dengue, the rate of dengue in Asia-Pacific region in expanding robustly. According a report published by Future Market Insights (FMI), …

Dengue vaccines Increasing Research and Development Projects to Spell Growth of the Market

Increasing prevalence of dengue fever throughout the Asia-Pacific region has propelled the demand for effectual medicines and vaccines to overcome this viral disease. While some pharmaceutical companies are focusing on development of a cure to dengue, the rate of dengue in Asia-Pacific region in expanding robustly. According a report published by Future Market Insights (FMI), …